{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:03:03Z","timestamp":1792065783654,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1432250, 81471773"],"award-info":[{"award-number":["U1432250, 81471773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473088"],"award-info":[{"award-number":["81473088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1532154"],"award-info":[{"award-number":["U1532154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703559"],"award-info":[{"award-number":["81703559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703007"],"award-info":[{"award-number":["81703007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21708044"],"award-info":[{"award-number":["21708044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFA0400900"],"award-info":[{"award-number":["2016YFA0400900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Science and Technology Program of Anhui Province","award":["16030801114"],"award-info":[{"award-number":["16030801114"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018M630721"],"award-info":[{"award-number":["2018M630721"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018T110633"],"award-info":[{"award-number":["2018T110633"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018T110634"],"award-info":[{"award-number":["2018T110634"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1808085MH268"],"award-info":[{"award-number":["1808085MH268"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1708085MH208"],"award-info":[{"award-number":["1708085MH208"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1808085MH274"],"award-info":[{"award-number":["1808085MH274"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1808085QH263"],"award-info":[{"award-number":["1808085QH263"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frontier Science Key Research Program of CAS","award":["QYZDB-SSW-SLH037"],"award-info":[{"award-number":["QYZDB-SSW-SLH037"]}]},{"name":"National Program for Support of Top-Notch Young Professionals"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejmech.2018.09.025","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T05:50:19Z","timestamp":1536817819000},"page":"896-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor"],"prefix":"10.1016","volume":"158","author":[{"given":"Beilei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenquan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-3591","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-2547","authenticated-orcid":false,"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.09.025_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer ii: cyclin D and CDK inhibitors come of age","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.09.025_bib2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.09.025_bib3","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.14.3.2066","article-title":"D-type cyclin-dependent kinase activity in mammalian cells","volume":"14","author":"Matsushime","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.09.025_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.09.025_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd2907","article-title":"Cell cycle kinases as therapeutic targets for cancer","volume":"8","author":"Lapenna","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.09.025_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejmech.2017.07.067","article-title":"Recent advances on CDK inhibitors: an insight by means of in silico methods","volume":"142","author":"Tutone","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.08.071","article-title":"Structural insights of cyclin dependent kinases: implications in design of selective inhibitors","volume":"142","author":"Kalra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2008.03.003","article-title":"Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology","volume":"29","author":"Wang","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.09.025_bib9","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1101\/gad.1235904","article-title":"Elongation by RNA polymerase ii: the short and long of it","volume":"18","author":"Sims","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2018.09.025_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(00)00278-X","article-title":"Transcriptional activity of P-TEFB kinase in\u00a0vivo requires the C-terminal domain of RNA polymerase ii","volume":"254","author":"Napolitano","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2018.09.025_bib11","first-page":"369","article-title":"CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells","volume":"1","author":"Bettayeb","year":"2010","journal-title":"Genes&Cancer"},{"key":"10.1016\/j.ejmech.2018.09.025_bib12","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1021\/acs.jmedchem.6b00150","article-title":"Cyclin dependent kinase 9 inhibitors for cancer therapy","volume":"59","author":"Sonawane","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.18632\/oncotarget.1568","article-title":"A\u00a0novel CDK9 inhibitor preferentially targets tumor cells and synergizes with fludarabine","volume":"5","author":"Walsby","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2018.09.025_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chembiol.2010.07.016","article-title":"Discovery and characterization of 2-Anilino-4-(Thiazol-5-yl)Pyrimidine transcriptional CDK inhibitors as anticancer agents","volume":"17","author":"Wang","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.09.025_bib15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2005-04-1678","article-title":"Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death","volume":"106","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.09.025_bib16","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2174\/138161212800672750","article-title":"Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target","volume":"18","author":"Vladimir","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.09.025_bib17","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/jm0305568","article-title":"N-(Cycloalkylamino)Acyl-2-Aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-Oxazolyl]Methyl]Thio]-2-Thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent","volume":"47","author":"Misra","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-008-0921-5","article-title":"SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples","volume":"64","author":"Conroy","year":"2009","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.025_bib19","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.2759.2759","article-title":"RGB 286638, a novel multi-targeted small molecule inhibitor, induces multiple myeloma (MM) cell death through abrogation of CDK-dependent and -independent survival mechanisms","volume":"112","author":"Cirstea","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2018.09.025_bib20","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/leu.2013.194","article-title":"Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs","volume":"27","author":"Cirstea","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.09.025_bib21","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/1535-7163.MCT-08-0836","article-title":"AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts","volume":"8","author":"Byth","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.025_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1535-7163.MCT-08-0890","article-title":"Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines","volume":"8","author":"Squires","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.025_bib23","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/leu.2015.31","article-title":"Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia","volume":"29","author":"Flynn","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.09.025_bib24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1535-7163.MCT-10-0324","article-title":"Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor","volume":"9","author":"Parry","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.025_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/ml100051d","article-title":"Discovery of dinaciclib (SCH 727965): a potent and selective inhibitor of cyclin-dependent kinases","volume":"1","author":"Paruch","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.09.025_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nchembio.2538","article-title":"Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation","volume":"14","author":"Olson","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.09.025_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm301475f","article-title":"Substituted 4-(Thiazol-5-yl)-2-(Phenylamino)Pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure\u2013activity relationship, and anticancer activities","volume":"56","author":"Shao","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib28","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and applications of halogen bonding in medicinal chemistry and chemical biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.025_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-2333(89)90039-8","article-title":"Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs","volume":"3","author":"Saotome","year":"1989","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2018.09.025_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A\u00a0small molecule\u2013kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2018.09.025_bib31","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1038\/cddis.2011.66","article-title":"Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1","volume":"2","author":"Polier","year":"2011","journal-title":"Cell Death Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T18:44:21Z","timestamp":1604947461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418307979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0223523418307979"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.025","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}